Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    Sun Pharmaceutical Industries Inc logo features a stylized sun design representing the companys name and pharmaceutical focus

    Sun Pharmaceutical Industries Inc.

    Sun Pharmaceutical Industries Inc. is a leading global specialty generic pharmaceutical company, manufacturing and distributing over 193 drugs in the U.S. and serving more than 100 countries worldwide.

    Company Overview

    Sun Pharmaceutical Industries Inc. operates as a major player in the pharmaceutical industry, specializing in generic and specialty medicines. With a robust portfolio spanning chronic and acute therapies, the company delivers high-quality pharmaceuticals to healthcare professionals and patients globally. Its U.S. division is ranked among the top in the generic dermatology market.

    Key Metrics

    1,200

    Import Shipments

    41

    Distribution Centers

    6.2B

    Annual Revenue

    1983

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Sun Pharmaceutical Industries Inc. has recently focused on expanding its specialty and biotechnology portfolio, enhancing global distribution, and investing in advanced research and development.

    Strategic Expansion

    Acquisition of Concert Pharmaceuticals to strengthen biotechnology capabilities

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Sun Pharmaceutical Industries Inc. manufactures, markets, and distributes a wide range of pharmaceutical products, including generics, branded generics, specialty drugs, and active pharmaceutical ingredients (APIs). The company’s U.S. operations are notable for their extensive product portfolio, with over 193 drugs available. Sun Pharma’s commitment to innovation is reflected in its significant investment in research and development, supporting the launch of technologically advanced and differentiated products. Its global footprint and manufacturing capabilities enable efficient distribution and access to medicines across diverse markets.

    Headquarters

    Mumbai, India

    Founded

    1983

    Stock Symbol

    SUNPHARMA